Domain-specific role of IL-17RA in controlling Klebsiella pneumoniae lung infection
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1R03HL154231-01
Grant search
Key facts
Disease
Bacterial infection caused by Klebsiella pneumoniaStart & end year
20202022Known Financial Commitments (USD)
$78,250Funder
National Institutes of Health (NIH)Principal Investigator
Giraldina Trevejo-NunezResearch Location
United States of AmericaLead Research Institution
UNIVERSITY OF PITTSBURGH AT PITTSBURGHResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
ABSTRACT IL-17 is an essential mediator of immunity to Klebsiella pneumoniae (KP). Animal models lacking IL-17 signaling or having IL-17 receptor (IL-17R) deficiency are susceptible to KP pneumonia. Although considerable research effort has focused on how Th17 cells are generated and regulated, the mechanisms by which IL-17 and its receptor IL-17R mediate specific downstream signals in relevant disease processes such as KP pneumonia are not fully elucidated. Our efforts to understand KP pneumonia in mouse models revealed that the distal domain of IL-17RA, also known as CBAD, is indispensable to control this infection. Thus, we propose to determine the immune and molecular mechanisms by which the IL-17RA CBAD domain constrains KP pneumonia. We will also perform parallel analyses to evaluate the cell-type-specific response by single-cell RNASeq. The findings generated from this proposal will help us understand IL-17- dependent signaling mechanism by which KP pneumonia can be controlled and to evaluate the lung immune response at a single cell resolution.